WittGen
Plug and Play · Single-cell GenAI decoding cancer's cellular secrets with virtual patient profiling, driving therapeutic breakthroughs in novel targets and biomarkers
Same space
| Company | Category | Status | Program |
|---|---|---|---|
| Other | Not stated | Plug and Play | |
| Other | Active | YCW20 | |
| Other | Acquired | YCW20 | |
| Other | Not stated | Plug and Play | |
| AI, Data, Devtools | Inactive | YCX25 |
Also from Plug and Play in AI
All of Plug and PlayPrograms
| Program | Cohort | Source |
|---|---|---|
| Not stated | Plug and Play Page |
About WittGen
"WittGen Biotechnologies is a pioneering health and lifetech company focused on leveraging AI to transform single-cell clarity into therapeutic opportunities for cancer. Utilizing single-cell RNA sequencing data analysis, WittGen overcomes the heterogeneity of cancer by offering services such as subtype prediction, grade determination, cell composition analysis, SNV and CNV identification, cancer origin tracking, risk scoring with pathway analysis, drug recommendations, and novel biomarker discovery. Founded in 2023 and headquartered in Berkeley, California, WittGen Biotechnologies is at the forefront of revolutionizing cancer treatment through advanced data analytics and personalized medicine approaches."
- Category
- AI, Data
- Location
- United States
- Checked
- 3h ago
WittGen: questions
Which accelerators did WittGen go through?
WittGen is listed by Plug and Play.
Where is WittGen based?
WittGen lists United States as its location on Plug and Play's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.